Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,162,329
+$1,262,079 QoQ
Shares Held
61,100
+88.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#195
of 494 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. ROIV ranks #15 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,162,329 | 61,100 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $900,250 | 32,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $984,029 | 45,347 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $756,605 | 50,007 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $563,578 | 50,007 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $493,471 | 48,907 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $408,135 | 34,500 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $520,765 | 45,127 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $485,765 | 45,957 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $521,276 | 49,457 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $409,412 | 36,457 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $355,620 | 30,447 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $256,304 | 25,427 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $154,980 | 21,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $167,790 | 21,000 | Shares | Sole | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||